| Revenues, EBT and total assets for reportable segments |
The table below presents revenues, EBT and total assets for reportable segments (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
March 31,
2019 |
|
March 25,
2018 |
|
March 31,
2019 |
|
March 25,
2018 |
Revenues |
|
|
|
|
|
|
|
QCT |
$ |
3,722 |
|
|
$ |
3,897 |
|
|
$ |
7,461 |
|
|
$ |
8,548 |
|
QTL |
1,122 |
|
|
1,219 |
|
|
2,141 |
|
|
2,485 |
|
QSI |
98 |
|
|
30 |
|
|
125 |
|
|
60 |
|
Reconciling items |
40 |
|
|
74 |
|
|
97 |
|
|
162 |
|
Total |
$ |
4,982 |
|
|
$ |
5,220 |
|
|
$ |
9,824 |
|
|
$ |
11,255 |
|
EBT |
|
|
|
|
|
|
|
QCT |
$ |
542 |
|
|
$ |
608 |
|
|
$ |
1,140 |
|
|
$ |
1,563 |
|
QTL |
674 |
|
|
809 |
|
|
1,264 |
|
|
1,664 |
|
QSI |
17 |
|
|
40 |
|
|
25 |
|
|
51 |
|
Reconciling items |
(427 |
) |
|
(1,140 |
) |
|
(1,063 |
) |
|
(3,020 |
) |
Total |
$ |
806 |
|
|
$ |
317 |
|
|
$ |
1,366 |
|
|
$ |
258 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31,
2019 |
|
September 30,
2018 |
Assets |
|
|
|
QCT |
$ |
2,948 |
|
|
$ |
3,041 |
|
QTL |
2,405 |
|
|
1,472 |
|
QSI |
1,393 |
|
|
1,279 |
|
Reconciling items |
27,277 |
|
|
26,926 |
|
Total |
$ |
34,023 |
|
|
$ |
32,718 |
|
|
| Reconciling items for reportable segments - revenues |
Reconciling items for revenues and EBT in the previous table were as follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
March 31,
2019 |
|
March 25,
2018 |
|
March 31,
2019 |
|
March 25,
2018 |
Revenues |
|
|
|
|
|
|
|
Nonreportable segments |
$ |
40 |
|
|
$ |
74 |
|
|
$ |
97 |
|
|
$ |
162 |
|
|
$ |
40 |
|
|
$ |
74 |
|
|
$ |
97 |
|
|
$ |
162 |
|
EBT |
|
|
|
|
|
|
|
Unallocated cost of revenues |
$ |
(104 |
) |
|
$ |
(111 |
) |
|
$ |
(218 |
) |
|
$ |
(228 |
) |
Unallocated research and development expenses |
(190 |
) |
|
(271 |
) |
|
(337 |
) |
|
(551 |
) |
Unallocated selling, general and administrative expenses |
(84 |
) |
|
(258 |
) |
|
(148 |
) |
|
(420 |
) |
Unallocated other income (expenses) (Note 2) |
18 |
|
|
(310 |
) |
|
(130 |
) |
|
(1,493 |
) |
Unallocated interest expense |
(159 |
) |
|
(179 |
) |
|
(313 |
) |
|
(348 |
) |
Unallocated investment and other income, net |
109 |
|
|
82 |
|
|
130 |
|
|
206 |
|
Nonreportable segments |
(17 |
) |
|
(93 |
) |
|
(47 |
) |
|
(186 |
) |
|
$ |
(427 |
) |
|
$ |
(1,140 |
) |
|
$ |
(1,063 |
) |
|
$ |
(3,020 |
) |
|
| Reconciling items for reportable segments - EBT |
Unallocated acquisition-related expenses were comprised as follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
March 31,
2019 |
|
March 25,
2018 |
|
March 31,
2019 |
|
March 25,
2018 |
Cost of revenues |
$ |
99 |
|
|
$ |
102 |
|
|
$ |
202 |
|
|
$ |
208 |
|
Research and development expenses |
1 |
|
|
2 |
|
|
2 |
|
|
3 |
|
Selling, general and administrative expenses |
7 |
|
|
214 |
|
|
14 |
|
|
290 |
|
Reconciling items for revenues and EBT in the previous table were as follows (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
March 31,
2019 |
|
March 25,
2018 |
|
March 31,
2019 |
|
March 25,
2018 |
Revenues |
|
|
|
|
|
|
|
Nonreportable segments |
$ |
40 |
|
|
$ |
74 |
|
|
$ |
97 |
|
|
$ |
162 |
|
|
$ |
40 |
|
|
$ |
74 |
|
|
$ |
97 |
|
|
$ |
162 |
|
EBT |
|
|
|
|
|
|
|
Unallocated cost of revenues |
$ |
(104 |
) |
|
$ |
(111 |
) |
|
$ |
(218 |
) |
|
$ |
(228 |
) |
Unallocated research and development expenses |
(190 |
) |
|
(271 |
) |
|
(337 |
) |
|
(551 |
) |
Unallocated selling, general and administrative expenses |
(84 |
) |
|
(258 |
) |
|
(148 |
) |
|
(420 |
) |
Unallocated other income (expenses) (Note 2) |
18 |
|
|
(310 |
) |
|
(130 |
) |
|
(1,493 |
) |
Unallocated interest expense |
(159 |
) |
|
(179 |
) |
|
(313 |
) |
|
(348 |
) |
Unallocated investment and other income, net |
109 |
|
|
82 |
|
|
130 |
|
|
206 |
|
Nonreportable segments |
(17 |
) |
|
(93 |
) |
|
(47 |
) |
|
(186 |
) |
|
$ |
(427 |
) |
|
$ |
(1,140 |
) |
|
$ |
(1,063 |
) |
|
$ |
(3,020 |
) |
|